Our findings indicate that a single dose of 5 μM sanguinarine results in a striking relocalization of cyclin D1 and topoisomerase II from the nucleus to the cytoplasm of MCF-7 breast cancer cells, along with an arrest of proliferation for at least six days. This evidence concerns the gene CCND1 and breast cancer.